New treatment brings hope to thousands of younger women with deadliest form of breast cancer, say experts

THOUSANDS of younger women with one of the deadliest breast cancers may benefit from a new drug, say experts.

Patients with triple negative cancer who also had the BRCA gene mutation were twice as likely to respond to carboplatin chemo as a standard form.

1

MOST READ IN HEALTH NEWS

MEDICAL MYSTERY

'Happy and outgoing' little girl is battling a condition so rare it has no name - so it may be named after her

CANCER SCARE

Most deadly skin cancers DON'T start in existing moles - here's how to spot the signs

'LIKE A REALLY BAD HANGOVER'

Man who blamed bloating on beer and pizza is actually battling cancer - but jokes 'a benefit of chemo is losing your ginger hair'

SEX CLUES

This is how much sex you SHOULD be having... according to your age

The aggressive cancers are most common in women under 40. London’s Institute of Cancer Research found tumours shrank in 68 per cent of 376 patients. The drug also delayed disease progression for seven months compared with four for current treatments.

Breast Cancer Now, which co-funded the trial, called it “a landmark step”.

GOT a news story? RING us on 0207 782 4104 or WHATSAPP on 07423720250 or EMAIL [email protected]